Cite

1. Blaser MJ. Helicobacter pylori: its role in disease. Clin Inf Dis. 1992; 15; 386-91.10.1093/clind/15.3.386Search in Google Scholar

2. Howden CW. Clinical expressions of Helicobacter pylori infection. Am J Med. 1996; 100: 27S-32S.10.1016/S0002-9343(96)80226-9Search in Google Scholar

3. Blaser MJ. Role of vacA and the cagA locus of Helicobacter pylori in human disease. Alim Pharm Therapeut. 1996; 10: 73-7.10.1046/j.1365-2036.1996.22164008.x8730262Search in Google Scholar

4. Robertson DJ, Sandler RS, Ahnen DJ, Greenberg ER, Mott LA, Cole BF, Baron JA. Gastrin, Helicobacter pylori, and colorectal adenomas. Clin Gastroenterol Hepatol. 2009; 7:163-7.10.1016/j.cgh.2008.09.00618929688Open DOISearch in Google Scholar

5. Breuer-Katschinski B, Nemes K, Marr A, Rump B, Leiendecker B, Breuer N, Goebell H. Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion. 1999; 60:210-5.10.1159/00000766110343134Open DOISearch in Google Scholar

6. Fireman Z, Trost L, Kopelman Y, Segal A, Sternberg A. Helicobacter pylori: seroprevalence and colorectal cancer. Isr Med Assoc J. 2000; 2:6-9.Search in Google Scholar

7. Shmuely H, Passaro D, Figer A, Niv Y, Pitlik S, Samra Z, et al. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol. 2001; 96:3406-10.10.1111/j.1572-0241.2001.05342.x11774957Search in Google Scholar

8. Hartwich J, Konturek SJ, Pierzchalski P, Zuchowicz M, Konturek PC, Bielanski W, et al. Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2. Med Sci Monit. 2001; 7:1171-81.Search in Google Scholar

9. Kim SS, Meitner P, Konkin TA, Cho YS, Resnick MB, Moss SF. Altered expression of Skp2, c-Myc and p27 proteins but not mRNA after H. pylori eradication in chronic gastritis. Mod Pathol. 2006; 19:49-58.10.1038/modpathol.380047616118628Search in Google Scholar

10. Cheng Y, Chaturvedi R, Asim M, Bussiére FI, Scholz A, Xu H, et al. Helicobacter pylori-induced macrophage apoptosis requires activation of ornithine decarboxylase by c-Myc. J Biol Chem. 2005; 280: 22492-6.10.1074/jbc.C50012220015843384Search in Google Scholar

11. Babu SD, Jayanthi V, Devaraj N, Reis CA, Devaraj H. Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium. Mol Cancer. 2006; 5:10.10.1186/1476-4598-5-10147936216545139Search in Google Scholar

12. Teixeira A, David L, Reis CA, Costa J, Sobrinho-Simoes M. Expression of mucins (MUC1, MUC2, MUC5AC, and MUC6) and type 1 Lewis antigens in cases with and without Helicobacter pylori colonization in metaplastic glands of the human stomach. J Pathol. 2002; 197:37-43.10.1002/path.108312081201Search in Google Scholar

13. Pelengaris S, Khan M. The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth. Expert Opin Ther Targets. 2003; 7:623-42.10.1517/14728222.7.5.623Search in Google Scholar

14. Hann SR. Role of post-translational modifications in regulating c-Myc proteolysis, transcriptional activity and biological function. Semin Cancer Biol. 2006; 16: 288-302.10.1016/j.semcancer.2006.08.004Open DOISearch in Google Scholar

15. Schmidt EV. The role of c-myc in cellular growth control. Oncogene. 1999; 18:2988-96.10.1038/sj.onc.1202751Open DOISearch in Google Scholar

16. Prochownik EV. c-Myc: linking transformation and genomic instability. Curr Mol Med. 2008; 8:446-58.10.2174/156652408785747988Search in Google Scholar

17. Tytgat KM, Buller HA, Opdam FJ, Kim YS, Einerhand AW, Dekker J. Biosynthesis of human colonic mucin: Muc2 is the prominent secretory mucin. Gastroenterology. 1994; 107:1352-63.10.1016/0016-5085(94)90537-1Search in Google Scholar

18. Gupta SC, Misra V, Singh PA, Misra SP, Srivastava M, Agrawal R. Mucin histochemistry - a simple and effective method for diagnosing premalignant and early malignant lesions of lower gastrointestinal tract. Indian J Pathol Microbiol. 1997; 40:327-33.Search in Google Scholar

19. Fujimori S, Ehara A, Seo T, Mitsui K, Sakamoto C. Primary small intestinal malignant tumors (a review) (in Japanese). Nippon Rinsho. 2008; 66:1286-1296.Search in Google Scholar

20. Brabletz T, Herrmann K, Jung A, Faller G, Kirchner T. Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol. 2000; 156:865-70.10.1016/S0002-9440(10)64955-3Search in Google Scholar

21. Ajioka Y, Allison LJ, Jass JR. Significance of MUC1 and MUC2 mucin expression in colorectal cancer. J Clin Pathol. 1996; 49:560-4.10.1136/jcp.49.7.5605005708813954Search in Google Scholar

22. Ajioka Y, Watanabe H, Jass JR. MUC1 and MUC2 mucins in flat and polypoid colorectal adenomas. J Clin Pathol. 1997; 50:417-21.10.1136/jcp.50.5.4174999459215126Open DOISearch in Google Scholar

23. Hakim FT, Flomerfelt FA, Boyiadzis M, Gress RE. Aging, immunity and cancer. Curr Opin Immunol. 2004; 16:151-6.10.1016/j.coi.2004.01.00915023406Open DOISearch in Google Scholar

24. Bach S, Makristathis A, Rotter M, Hirschl AM. Gene expression profiling in AGS cells stimulated with Helicobacter pylori isogenic strains (cagA positive or cagA negative). Infect Immun. 2002; 70:988-92.10.1128/IAI.70.2.988-992.200212767111796637Search in Google Scholar

25. Wang J, Chi DS, Kalin GB, Sosinski C, Miller LE, Burja I, Thomas E. Helicobacter pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions. Dig Dis Sci. 2002; 47:107-13.10.1023/A:1013223722331Search in Google Scholar

26. Zhan N, Xiong YY, Lan J, Wang BC, Tian SF, Yu SP. Relationship between Helicobacter pylori infection and expression of c-myc, Bcl-2, and Bax protein in different gastric mucosa lesions (in Chinese). Ai Zheng. 2003; 22:1034-7.Search in Google Scholar

27. Cao Q, Ran ZH, Xiao SD. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies. J Dig Dis. 2007; 8:15-22.10.1111/j.1443-9573.2007.00271.xSearch in Google Scholar

28. Micots I, Augeron C, Laboisse CL, Muzeau F, Megraud F. Mucin exocytosis: a major target for Helicobacter pylori. J Clin Pathol. 1993; 46:241-5.10.1136/jcp.46.3.241Open DOISearch in Google Scholar

29. Byrd JC, Yunker CK, Xu QS, Sternberg LR, Bresalier RS. Inhibition of gastric mucin synthesis by Helicobacter pylori. Gastroenterology. 2000; 118: 1072-9.10.1016/S0016-5085(00)70360-XSearch in Google Scholar

eISSN:
1875-855X
Language:
English
Publication timeframe:
6 times per year
Journal Subjects:
Medicine, Assistive Professions, Nursing, Basic Medical Science, other, Clinical Medicine